Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-03-08
2011-03-08
Minnifield, N. M (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007320, C435S975000, C530S300000
Reexamination Certificate
active
07901898
ABSTRACT:
A method of diagnosing in a host infection by or exposure to a mycobacterium which expresses ESAT-6 comprising (i) contacting a population of T cells from the host with one or more peptides or analogues selected from the peptides represented by SEQ ID NO:1 to 11 and analogues thereof which can bind a T cell receptor which recognises any of the said peptides, and (ii) determining whether the T cells of said T cell population recognise the peptide(s) and/or analogue(s). The method may performed in vivo. Peptides and a kit which enable the method to be carried out are provided.
REFERENCES:
patent: 5736524 (1998-04-01), Content et al.
patent: 5955077 (1999-09-01), Andersen et al.
patent: 6245331 (2001-06-01), Laal et al.
patent: 6290969 (2001-09-01), Reed et al.
patent: 6338852 (2002-01-01), Reed et al.
patent: 6350456 (2002-02-01), Reed et al.
patent: 6384018 (2002-05-01), Content et al.
patent: 6458366 (2002-10-01), Reed et al.
patent: 6537552 (2003-03-01), Minion et al.
patent: 6596281 (2003-07-01), Gennaro et al.
patent: 6613881 (2003-09-01), Alderson et al.
patent: 6641814 (2003-11-01), Andersen et al.
patent: 6649170 (2003-11-01), Lindblad et al.
patent: 6673353 (2004-01-01), Kaufmann et al.
patent: 6776993 (2004-08-01), Kaufmann et al.
patent: 6962710 (2005-11-01), Reed et al.
patent: 6982085 (2006-01-01), Andersen et al.
patent: 6991797 (2006-01-01), Andersen et al.
patent: 7037510 (2006-05-01), Andersen et al.
patent: 7087713 (2006-08-01), Campos-Neto et al.
patent: 7115361 (2006-10-01), Lalvani et al.
patent: 7122196 (2006-10-01), Reed et al.
patent: 7135280 (2006-11-01), Lalvani
patent: 7238358 (2007-07-01), Reed et al.
patent: 7261897 (2007-08-01), Skeiky et al.
patent: 7393539 (2008-07-01), James et al.
patent: 7572597 (2009-08-01), Lalvani et al.
patent: 7575870 (2009-08-01), Lalvani et al.
patent: 7632646 (2009-12-01), Lalvani et al.
patent: 7785607 (2010-08-01), Goletti et al.
patent: 7811588 (2010-10-01), James et al.
patent: 2002/0094336 (2002-07-01), Andersen et al.
patent: 2002/0131976 (2002-09-01), Lalvani et al.
patent: 2003/0044431 (2003-03-01), Schurig et al.
patent: 2004/0115211 (2004-06-01), Andersen et al.
patent: 2006/0019323 (2006-01-01), Leclerc et al.
patent: 2006/0115847 (2006-06-01), Andersen et al.
patent: 2006/0121537 (2006-06-01), Gahery-Segard et al.
patent: 2007/0036816 (2007-02-01), Campos-Neto et al.
patent: 2007/0184073 (2007-08-01), Andersen et al.
patent: 2008/0008724 (2008-01-01), Aagaard et al.
patent: 2008/0124738 (2008-05-01), Green
patent: 2008/0267990 (2008-10-01), Andersen et al.
patent: 2008/0311159 (2008-12-01), Klein et al.
patent: 2009/0074803 (2009-03-01), Sallberg et al.
patent: 2009/0136534 (2009-05-01), Shafferman et al.
patent: 2010/0159485 (2010-06-01), Mukhopadhyay et al.
patent: 1152012 (2007-07-01), None
patent: WO9501441 (1995-01-01), None
patent: WO9816646 (1998-04-01), None
patent: WO9823960 (1998-06-01), None
patent: WO9945119 (1999-09-01), None
patent: WO02154072 (2002-07-01), None
patent: WO 2008/032092 (2008-03-01), None
Lalvani et al, Eur. Resp. J. 2008, 32/6:1428-1430.
Dinnes et al, Health Technology Assessment, Jan. 2007, 11/3:1-178 abstract only.
Harada, Kekkaku, Nov. 2006, 81/11:681-686 abstract only.
Ruhwald et al, Expt. Rev. Resp. Med., Aug. 2009, 3/4:387-401 abstract only.
U.S. Appl. No. 09/830,839, filed Feb. 19, 2002, Lalvani et al.
Andersen, Trends in Immunology, Mar. 2001, 22/3:160-168.
Arend et al., J. Infectious Diseases, 2000, 181:1850-1854.
Bixler et al., in: Synthetic Vaccines, vol. 1, Editor: Arnon, 1987, pp. 39-71.
Bowie et al., Science, Mar. 1990, 247:1306-1310.
Brandt, et al., “Key Epitopes on the ESAT-6 Antigen Recognized in Mice During the Recall of Protective Immunity to Mycobacterium Tuberculosis”, J. Immunol., vol. 1996, No. 157, 1996. p. 3527-3533.
Brodin et al., Trends in Microbiology, Nov. 2004, 12/11:500-508.
Buddle et al., Vet. Microbiology, 2001, 80:37-46.
Burgess et al., J. Cell Biology, Nov. 1990, 111:2129-2138.
Chothia et al., The EMBO Journal, 1986, 5/4: 823-826.
Demissie et al., Infection and Immunity, Nov. 1999, 67/11:5967-5971.
Elhay, M.J. et al., “Delayed-Type Hypersensitity Responses to ESAT-6 and MPT64 from Mycobacterium Tuberculosis in the Guinea Pig”, Infect Immun., vol. 66, No. 7, Jul. 1998, p. 3454-3456.
Geluk et al., Infection and Immunity, May 2002, 70/5:2544-2548.
Glatmen-Freedman et al., Clinical Microbiology Reviews, Jul. 1998, 11/3:514-532.
Greenspan et al., Nature Biotechnology, Oct. 1999, 17:936-937.
Harboe, M. et al., “B-Bell Epitopes and Quantification of the ESAT-6 Protein of Mycobacterium Tuberculosis”, Infect. Immun., vol. 66, No. 2, Feb. 1998, p. 717-723.
Houghten et al., Vaccines 86, 1986, Editors: Brown et al., pp. 21-25.
International Search Report, Apr. 19, 2000, PCT/GB1999/03635, International Filing Date—Nov. 3, 1999.
Kanaujia et al., Clin. Diagn. Lab. Immunol., Jan. 2004, 11/1:222-226.
Kumar et al., PNAS, USA, Feb. 1990, 87:1337-1341.
Lalvani & Hill, (1998), MRS Meeting of May 15, 1997, Royal College of Physicians London, Clinical Science 95, 531-538.
Lalvani et al. (Jan. 1998) Proc. Natl. Acad. Sci. USA 95, 270-275.
Lalvani et al., Am. J. Respiratory Critical Care Medicine, 2001, 163:824-828.
Lalvani et al., J. Infectious Diseases, 2001, 183:469-477.
Lazar et al., Molecular and Cellular Biology, Mar. 1988, 8/3:1247-1252.
Lowrie et al., BioDrugs, 1998, 10/3:201-213.
Lowrie et al., Springer Seminars in Immunopathology, 1997, 19:161-173.
Minion et al., Infection and Immunity, Apr. 2003, 71/4:2239-2243.
Mollenkopf et al., Vaccine, 2001, 19:4028-4035.
Morris et al., Vaccine, 2000, 18:2155-2163.
Mustafa et al., Clinical Infectious Diseases, 2000, 30/Suppl. 3:S201-S205.
Mustafa et al., Scandinavian J. Immunology, 2003, 57:125-135.
Mustafa, Molecular Immunology, 2002, 39:113-119.
Olsen et al., Eur. J. Immunol., Jun. 2000, 30/6:1724-1732; Abstract only.
Pathan, A. et al., “Human T-Cell Responses to the Antigen ESAT-6 Cgaracteruze a Vacube Candidate and Potential Diagnostic Test for Tuberculosis”, Immunology, vol. 95, No. Suppl. 1, Dec. 1998, p. 90.
Pathan, A. et al., “Identification of Conserved CD8+ Cytotoxic T Cell Epitopes in ESAT-6, a Tuberculosis Vaccine Candidate”, Immunology, vol. 95, No. Suppl. 1, Dec. 1998, p. 108.
Pollock & Anderson (1997) J. Infect. Diseases 175, 1251-1254.
Rhodes et al., Infection and Immunity, May 2000, 68/5:2573-2578.
Saleem et al., J. Controlled Release, 2005, 102:551-561.
Scarpellini et al., J. Clinical Microbiology, Aug. 2004, 42/8:3469-3474.
Sinha et al., Comparative and Functional Genomics, 2002, 3:470-483.
Skjot et al., Infection and Immunity, Jan. 2000, 68/1:214-220.
Skjot et al., Infection and Immunity, Oct. 2002, 70/10:5446-5453.
Skjot et al., Scand. J. Infectious Disease, 2001, 33:643-647.
Sorenson et al. (1995) Infect. Immun. 63, 1710-1717.
Spencer et al., Infection and Immunity, Feb. 2002, 70/2:1010-1013.
Thorn et al., Vet. Immunol. and Immunopathol., 2004, 103:399-412.
Trajkovic et al., Microbes and Infections, 2004, 6:513-519.
Ulrichs et al., International J. tuberculosis and Lung Disease, 2000, 4/12:1181-1183.
Ulrichs, T. et al., “Differential T Cell Responses to Mycobacterium Tuberculosis ESAT-6 in Tuberculosis Patients and Healthy Donors”, Eur. J. Immunol., vol. 28, No. 12, Dec. 1998, p. 3949-3958.
van Pinxteren et al., Clinical and Diagnostic Laboratory Immunology, Mar. 2000, 7/2:155-160.
van Pittius et al., Infection and Immunity, Nov. 2002, 70/11:6509-6511.
Vekemans et al., Infection and Immunity, Oct. 2001, 69/10:6554-6557.
Vincenti et al., Mol. Med., Mar.-Apr. 2003, 9/3-4:105-111; Abstract only.
Vordermeier et al., Clinical and Diagnostic Laboratory Immunology Sep. 1999, 6/5:675-682.
Vordermeier et al., Clinical and Diagnostic Laboratory Immunology, May 2001, 8/3:571-578.
Vordermeier et al., Clinical Infectious Diseases, 2000, 30 (Suppl. 3):S291-S298.
Vordermeier et al., Eur. Respir. J., 1995, 8/Suppl. 20:657s-667s.
Vordermeier et al., Infection and Immunity, Apr. 2003, 71/4:1980-1987.
U.S. Appl. No. 0
Lalvani Ajit
Pathan Ansar
Baker & Botts L.L.P.
Isis Innovation Limited
Minnifield N. M
LandOfFree
Tuberculosis diagnostic test does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tuberculosis diagnostic test, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tuberculosis diagnostic test will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2690681